[1].胡善联,刘国恩等.我国糖尿病流行病学和疾病经济负担研究现状[J].中国卫生经济,2008, 27(8):5-8. [2]. People’s Daily Online. China has annual increase of 1.2 million diabetes patients [EB/OL] . http://english.peopledaily. com.cn /200011/14/eng 20001114_55162.html, 2008- 02- 29. [3]. World health organization.Definition, diagnosis and classification of diabetes mellitus and its complication[J].WHO/NCD/NCS, 1999,31. [4]. 李洪超, 张心科. 阿法骨化醇治疗骨质疏松的疗效[J].中国药物经济学,2011,(3):49-78. [5]. 高鑫,江孙芳等.国产格列美脲治疗2型糖尿病的临床疗效[J]. 中国临床药学杂志,2001,10(3):137-139. [6]. 董淑雯,孙丽萍.格列美脲(98例)与格列本脲( 87例)治疗2型糖尿病的比较[J]. 中国新药与临床杂志, 2004,23(4):203-205. [7]. 董艳,陈雪茹,冯绮文.国产格列美脲治疗2型糖尿病的疗效和安全性[J].中国医师杂志,2006,8(1):120-123. [8].郝娜,格列美脲治疗2 型糖尿病临床分析[J]. 河北联合大学学报,2013,15(3):387-388. [9].宋春青,格列美脲治疗2型糖尿病的临床观察[J].中国城乡企业卫生,2003,10(5). [10].郭钦惠,格列美脲治疗2 型糖尿病有效性及安全性系统评价[J].中国现代医生,2010,48(19). [11]. 李贵湘等,格列美脲与格列苯脲治疗2 型糖尿病的临床观察[J].中国热带医学,2009,9(1):82. [12]. Dan-yan Xu et al. Effects of Glimepiride on metabolic parameters and cardiovascular risk factors in patients with newly diagnosed type 2 diabetes mellitus [J]. Diabetes Research and Clinical Practice,2010,88:71-75. [13].吴护群.格列美脲与格列苯脲对胰岛素抵抗和胰岛细胞功能的影响[J].吉林医学,2012,33(27):5899-5900. [14].Gonzalez-Ortiz,M.etal, Efficacy of glimepiride/metformin combination versus glibenclamide/ metformin in patients with uncontrolled type 2 diabetes mellitus. [J].Diabetes Complications, 2009. 23(6): p. 376-9. [15]. Dills, D.G. and J. Schneider, Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group. [J].Horm Metab Res, 1996. 28(9): p. 426-9. [16]. Inukai, K., et al., Efficacy of glimepiride in Japanese type 2 diabetic subjects. [J].Diabetes Res Clin Pract, 2005. 68(3): p. 250-7.
|